Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study.
Arends S, Brouwer E, van der Veer E, Groen H, Leijsma MK, Houtman PM, Th A Jansen TL, Kallenberg CG, Spoorenberg A. Arends S, et al. Among authors: leijsma mk. Arthritis Res Ther. 2011 Jun 20;13(3):R94. doi: 10.1186/ar3369. Arthritis Res Ther. 2011. PMID: 21689401 Free PMC article.
The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis.
Arends S, Spoorenberg A, Bruyn GA, Houtman PM, Leijsma MK, Kallenberg CG, Brouwer E, van der Veer E. Arends S, et al. Among authors: leijsma mk. Osteoporos Int. 2011 May;22(5):1431-9. doi: 10.1007/s00198-010-1338-7. Epub 2010 Jul 6. Osteoporos Int. 2011. PMID: 20603707 Free PMC article.
The effect of three years of TNFα blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study.
Arends S, Spoorenberg A, Houtman PM, Leijsma MK, Bos R, Kallenberg CG, Groen H, Brouwer E, van der Veer E. Arends S, et al. Among authors: leijsma mk. Arthritis Res Ther. 2012 Apr 30;14(2):R98. doi: 10.1186/ar3823. Arthritis Res Ther. 2012. PMID: 22546520 Free PMC article.
A genetic variant in granzyme B is associated with progression of joint destruction in rheumatoid arthritis.
Knevel R, Krabben A, Wilson AG, Brouwer E, Leijsma MK, Lindqvist E, de Rooy DP, Daha NA, van der Linden MP, Tsonaka S, Zhernakova A, Westra HJ, Franke L, Houwing-Duistermaat JJ, Toes RE, Huizinga TW, Saxne T, van der Helm-van Mil AH. Knevel R, et al. Among authors: leijsma mk. Arthritis Rheum. 2013 Mar;65(3):582-9. doi: 10.1002/art.37808. Arthritis Rheum. 2013. PMID: 23440692 Free article.
Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis.
de Rooy DP, Yeremenko NG, Wilson AG, Knevel R, Lindqvist E, Saxne T, Krabben A, Leijsma MK, Daha NA, Tsonaka S, Zhernakova A, Houwing-Duistermaat JJ, Huizinga TW, Toes RE, Baeten DL, Brouwer E, van der Helm-van Mil AH. de Rooy DP, et al. Among authors: leijsma mk. Ann Rheum Dis. 2013 May;72(5):769-75. doi: 10.1136/annrheumdis-2012-202184. Epub 2012 Oct 5. Ann Rheum Dis. 2013. PMID: 23041840
A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis.
Knevel R, de Rooy DP, Saxne T, Lindqvist E, Leijsma MK, Daha NA, Koeleman BP, Tsonaka R, Houwing-Duistermaat JJ, Schonkeren JJ, Toes RE, Huizinga TW, Brouwer E, Wilson AG, van der Helm-van Mil AH. Knevel R, et al. Among authors: leijsma mk. Arthritis Res Ther. 2014 May 7;16(3):R108. doi: 10.1186/ar4558. Arthritis Res Ther. 2014. PMID: 24886600 Free PMC article.
14 results